@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAIKJcDQPqdF8wrC47VhHEUmkaAigJ9XuutvLv3bSa2ZM> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAIKJcDQPqdF8wrC47VhHEUmkaAigJ9XuutvLv3bSa2ZM#> .
@prefix beldoc: <http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix chebi: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix hgnc: <http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix hasPart: <http://purl.obolibrary.org/obo/BFO_0000051> .
@prefix ProteinComplex: <http://amigo.geneontology.org/amigo/term/GO:0043234> .
@prefix mesh: <http://purl.bioontology.org/ontology/MSH/> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   sub:_1 hasPart: sub:_2 , sub:_3 ;
    a ProteinComplex: .
  sub:_2 geneProductOf: hgnc:1681 ;
    a Protein: .
  sub:_3 geneProductOf: hgnc:6110 ;
    a Protein: .
  sub:_4 occursIn: mesh:D010053 , species:9606 ;
    rdf:object sub:_1 ;
    rdf:predicate belv:directlyIncreases ;
    rdf:subject chebi:5772 ;
    a rdf:Statement .
  sub:assertion rdfs:label "a(CHEBI:\"hyaluronic acid\") => complex(p(HGNC:CD44),p(HGNC:IQGAP1))" .
}
sub:provenance {
   beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_6 ;
    pav:version "1.4" .
  sub:_5 prov:value "Ovarian cancer cells express CD44 isoforms that cause very strong cell adhesion to HA-enriched peritoneal mesothelium. The binding of HA to CD44 isoforms triggers direct \\\"cross-talk\\\" between two different tyrosine kinase (e.g. p185HER2 tyrosine kinase (5) and c-Src kinase (6))-linked signaling pathways (cell growth versus cell migration, respectively) in ovarian tumor cells. Our results indicate that HA treatment caused the recruitment of a significant amount of IQGAP1 (Fig. 1C, panel a, lane 2) into the CD44 complex (panel c, lane 2)." ;
    prov:wasQuotedFrom pubmed:15655247 .
  sub:_6 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:15655247 ;
    prov:wasDerivedFrom beldoc: , sub:_5 .
}
sub:pubinfo {
   this: dct:created "2014-07-03T14:30:30.948+02:00"^^xsd:dateTime ;
    pav:createdBy orcid:0000-0001-6818-334X , orcid:0000-0002-1267-0234 .
}